Holen Sie sich die Stockscreener-App
3.22
3.54%
0.11
Handel nachbörslich:
3.34
0.12
+3.73%
Schlusskurs vom Vortag:
$3.11
Offen:
$3.1
24-Stunden-Volumen:
29,328
Relative Volume:
1.30
Marktkapitalisierung:
$5.16M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-36.46M
KGV:
-20.12
EPS:
-0.16
Netto-Cashflow:
$-30.20M
1W Leistung:
+3.21%
1M Leistung:
+24.32%
6M Leistung:
-82.21%
1J Leistung:
-83.71%
1-Tages-Spanne:
$3.10
$3.29
1-Wochen-Bereich:
$2.9009
$4.18
52-Wochen-Spanne:
$2.07
$32.85
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Firmenname
Alaunos Therapeutics Inc
Sektor
Branche
Telefon
(346) 355-4099
Adresse
2617 BISSONNET ST, HOUSTON
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-04 | Fortgesetzt | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Aktie (TCRT) Neueste Nachrichten
Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer (NASDAQ:APLT) - Seeking Alpha
An Analysis of Atricure Inc (ATRC)’s Potential Price Growth - Knox Daily
Applied Therapeutics Surges on Positive FDA Update for Govorestat - BP Journal
Applied Therapeutics jumps as US FDA cancels panel meeting for genetic disorder drug - XM
Daily Market Movement: Atricure Inc (ATRC) Sees a -3.23 Decrease, Closing at 27.30 - The Dwinnex
Aptevo Therapeutics announces $3.0M offering priced at-the-market - TipRanks
Check out these key findings about Atricure Inc (ATRC) - SETE News
Atmos Energy Co. (NYSE:ATO) Shares Sold by Prudential PLC - MarketBeat
TCRT stock touches 52-week low at $2.28 amid market challenges - Investing.com India
TCRT stock touches 52-week low at $2.28 amid market challenges - Investing.com Canada
TCRT stock touches 52-week low at $2.28 amid market challenges - Investing.com
TCRT stock touches 52-week low at $2.28 amid market challenges - Investing.com UK
Ziopharm: Q2 Earnings Snapshot - San Antonio Express-News
Ziopharm: Q2 Earnings Snapshot - The Washington Post
Ziopharm: Q2 Earnings Snapshot - Weatherford Democrat
Eli Lilly inaugurates R&D facility in Boston, US - Pharmaceutical Technology
Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 4.2% - Defense World
TCRT stock touches 52-week low at $3.57 amid market challenges - Investing.com Nigeria
Alaunos Therapeutics announces 1-for-10 reverse stock split By Investing.com - Investing.com Australia
Alaunos Therapeutics announces 1-for-10 reverse stock split - Investing.com
Alaunos Therapeutics announces 1-for-10 reverse stock split By Investing.com - Investing.com UK
XyloCor taps SmartWise’s infusion device for gene therapy administration - Clinical Trials Arena
Intracranial Therapeutic Industry Startegy Analysis} Novartis AG, BioMarin, CORESTEM Inc., Alaunos Therapeutics ... - Economica
Alaunos (TCRT) Dips More Than Broader Markets: What You Should Know - Yahoo New Zealand News
Zacks Industry Outlook Highlights Dyne Therapeutics, Silence Therapeutics, Alaunos Therapeutics, Assertio Holdings ... - Yahoo Lifestyle UK
Alaunos Therapeutics appoints new accounting firmInvesting.com ZA - Investing.com South Africa
Alaunos Therapeutics appoints new accounting firm By Investing.com - Investing.com
Alaunos Therapeutics appoints new accounting firm - Investing.com India
Ziopharm Oncology to Participate in Upcoming Conferences - Quantisnow
Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25 ... - Quantisnow
Alaunos Therapeutics Appoints Abhishek Srivastava, Ph.D. as Vice President, Technical Operations - Quantisnow
Alaunos (TCRT) Dips More Than Broader Markets: What You Should Know - Yahoo Lifestyle Singapore
New Strong Buy Stocks for November 18th - Yahoo Movies Canada
Commerce Bank Decreases Stock Position in Alaunos Therapeutics, Inc. (NASDAQ:TCRT) - Defense World
The past five years for Alaunos Therapeutics (NASDAQ:TCRT) investors has not been profitable - Yahoo News Australia
Quarterly Metrics: Quick and Current Ratios for Alaunos Therapeutics Inc (TCRT) – DWinneX - The Dwinnex
Alaunos Therapeutics Reports First Quarter 2023 Financial Results - br.ADVFN.com
AltruBio secures $225m for immune checkpoint programme development - Pharmaceutical Technology
Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 3.6% - Defense World
Alaunos Therapeutics (NASDAQ:TCRT) investors are sitting on a loss of 78% if they invested three years ago - Yahoo Lifestyle UK
Ziopharm: Q1 Earnings Snapshot - Milford Mirror
Alaunos (TCRT) Stock Sinks As Market Gains: What You Should Know - Yahoo Lifestyle Australia
Avenzo Therapeutics secures $150m to bolster oncology pipeline - Pharmaceutical Technology
Alaunos Therapeutics Announces Executive Financial Leadership ChangesTipRanks.com - TipRanks
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Markets Insider
Alaunos Therapeutics Announces 1-for-15 Reverse Stock Split - TipRanks
Kyowa Kirin acquires Orchard Therapeutics for $477.6m - Pharmaceutical Technology
NAYA buys gene therapy company Florida Biotech for $20m - Clinical Trials Arena
Genentech signs nanoparticle deal worth up to $644m with GenEdit - Pharmaceutical Technology
BridGene and Galapagos partner for oncology drugs discovery - Pharmaceutical Technology
Novartis allies with Voyager to develop gene therapies in $1.3bn deal - Pharmaceutical Technology
Finanzdaten der Alaunos Therapeutics Inc-Aktie (TCRT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
4.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):